Click to copy
Click to copy

Insmed: 2Q Earnings Snapshot

August 1, 2019

BRIDGEWATER, N.J. (AP) _ Insmed Inc. (INSM) on Thursday reported a loss of $66.5 million in its second quarter.

The Bridgewater, New Jersey-based company said it had a loss of 81 cents per share.

The results surpassed Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was for a loss of 85 cents per share.

The biopharmaceutical developing inhaled treatments for patients battling rare lung diseases posted revenue of $30 million in the period, also exceeding Street forecasts. Three analysts surveyed by Zacks expected $24.9 million.

Insmed shares have increased 67% since the beginning of the year. The stock has dropped 12% in the last 12 months.


This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on INSM at https://www.zacks.com/ap/INSM

All contents © copyright 2019 The Associated Press. All rights reserved.